Results 21 to 30 of about 624 (144)

Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force [PDF]

open access: yes, 2019
Background: Impairments in affective cognition are part of the neurocognitive profile and possible treatment targets in bipolar disorder (BD), but the findings are heterogeneous. The International Society of Bipolar Disorder (ISBD) Targeting Cognition
Carlos López‐Jaramillo   +51 more
core   +3 more sources

Understanding the Current State of Play of Early Intervention for Bipolar Disorder: Qualitative Analysis of Consultations With International Stakeholders

open access: yesBipolar Disorders, Volume 28, Issue 2, March 2026.
ABSTRACT Background Despite the burden associated with bipolar disorder (BD), research into early diagnosis and treatment of BD lags approximately 20 years behind the field of early intervention for psychosis. This study evolved through a partnership between Orygen (Melbourne, Australia) and the Daymark Foundation (Toronto, Canada).
Sue M. Cotton   +12 more
wiley   +1 more source

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

open access: yes, 2013
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar ...
A Serretti (13318149)   +66 more
core   +3 more sources

ISBD – from Past to the Future [PDF]

open access: yes, 2013
Rad daje povijesni pregled razvoja ISBD-a s naglaskom na važnost ISBD-a za ostvarivanje Univerzalnoga bibliografskog nadzora. Prikazana su dva opća projekta preradbe. Slijedi opis nastanka i razvoja objedinjenog izdanja.
Barbarić, Ana, Radovčić, Marija
core  

Cognitive Impairment in Patients With Schizophrenia and Its Relationship With Adverse Childhood Experiences

open access: yesMental Illness, Volume 2026, Issue 1, 2026.
Cognitive impairment is now considered a core feature of schizophrenia (SCZ) that contributes to poor clinical outcomes. Clinical and socioenvironmental factors may play a key role in shaping cognitive functioning. In the present study, we aim to assess cognitive impairment in patients with SCZ or schizoaffective disorder and to explore whether adverse
Nada Charfi   +9 more
wiley   +1 more source

A Cross‐Sectional Analysis of Social Determinants of Health in Bipolar Disorder: Exploring Gender‐Related Differences

open access: yesBipolar Disorders, Volume 27, Issue 8, Page 545-550, December 2025.
ABSTRACT Objectives To explore the clinical impact of social determinants of health (SDoH) stress in bipolar disorder (BD) course of illness and to explore potential gender differences in SDoH stress endorsement. Methods 2280 individuals living with BD type I or II (62% women; 67.5% BD‐I) participating in the Mayo Clinic Bipolar Biobank who completed a
Manuel Gardea‐Resendez   +19 more
wiley   +1 more source

Association Between Adherence Barriers, Self‐Reported Adherence, and Psychiatric Symptoms Among Adults With Bipolar Disorder

open access: yesBipolar Disorders, Volume 27, Issue 8, Page 567-577, December 2025.
ABSTRACT Aims While suboptimal medication adherence is a widely recognized problem for people with bipolar disorder (BD), it is less clear how individual characteristics are associated with varying levels of adherence and how specific adherence barriers impact behaviors.
Martha Sajatovic   +9 more
wiley   +1 more source

Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting

open access: yesBipolar Disorders, Volume 27, Issue 7, Page 519-526, November 2025.
ABSTRACT Background Lithium blood levels are measured routinely 12 h after lithium dosing, but no study has evaluated the actual compliance of patients with the 12‐h levels. Methods First, we used the US multicenter clinical trial “Bipolar CHOICE” (n = 145 patients treated with lithium with N = 287 lithium blood tests), where participants reported the ...
Søren L. Jacobsen   +4 more
wiley   +1 more source

Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 688-701, October 2025.
ABSTRACT Depression is the leading cause of disability worldwide, affecting people of all ages. Both pharmacological and non‐pharmacological therapies are available for its treatment. However, some patients do not respond to first‐line pharmacological interventions, referred to as treatment‐resistant depression (TRD).
Angela Acero‐González   +8 more
wiley   +1 more source

ISBD: printed serial publications [PDF]

open access: yes, 2016
Ovaj se završni rad bavi tiskanim serijskim publikacijama koje su vrlo složena građa kada je u pitanju njihov opis. Prikazuje se ukratko opća važnost Međunarodnog standardnog bibliografskog opisa te se razrađuje ISBD(CR) standard za serijske publikacije ...
Režan, Marica
core  

Home - About - Disclaimer - Privacy